PUBLIC COMPANY
saveSeqirus Ltd
updated 2mo ago
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
community read0 votes
pipeline
7
marketed
5
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(7)
pipeline depth7 products
1Phase 21Phase 35Marketed
Marketed
Fluad (Quadrivalent)
Influenza A Virus, H1N1 Subtype Infections
MarketedFluad (Trivalent)
Influenza A Virus, H1N1 Subtype Infections
Marketedinfluenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
Influenza A Virus, H1N1 Subtype Infections
Marketedinfluenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine
Influenza A Virus, H1N1 Subtype Infections
Marketedinfluenza [types A and B] (quadrivalent) vaccine
Influenza A Virus, H1N1 Subtype Infections
Phase 3zapomeran
Coronavirus Disease 2019 (COVID-19)
Phase 2ARCT-165
Coronavirus Disease 2019 (COVID-19)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that